4.7 Review

Laser-Assisted Drug Delivery: A Systematic Review of Safety and Adverse Events

期刊

PHARMACEUTICS
卷 14, 期 12, 页码 -

出版社

MDPI
DOI: 10.3390/pharmaceutics14122738

关键词

lasers; laser-assisted; laser-facilitated; laser-assisted drug delivery; skin; dermal; dermatology; topical; cutaneous; human; human studies; clinical manifestations; clinical signs; symptoms; safety; adverse events

向作者/读者索取更多资源

Laser-assisted drug delivery (LADD) is a growingly studied and applied methodology for drug delivery. This systematic review aimed to assess the safety outcomes of LADD and found that it can lead to adverse effects such as erythema, oedema, pain, and crusting. However, no life-threatening adverse effects were reported. Further research is needed to quantitatively determine the risks.
Laser-assisted drug delivery (LADD) is an increasingly studied and applied methodology for drug delivery. It has been used in a wide variety of clinical applications. Given the relatively low barrier to entry for clinicians as well as ongoing research in this area, the authors aimed to review outcomes relating to safety in laser-assisted drug delivery. A systematic review was conducted, with the databases PubMed, Medline and Embase searched in September 2022. Included articles were those that mentioned laser-assisted drug delivery in human subjects that also reported adverse effects or safety outcomes. There were no language-based exclusions. Conference abstracts and literature reviews were excluded. The results were then tabulated and categorized according to the application of LADD. In total, 501 articles were obtained. Following deduplication, screening, and full text review 70 articles of various study designs were included. Common findings were erythema, oedema, pain, and crusting following LADD. Several notably more severe adverse effects such as generalized urticaria, infection, scarring and dyspigmentation were noted. However, these events were varied depending on the clinical use of LADD. Relevant negatives were also noted whereby no studies reported life-threatening adverse effects. Limitations included limited details regarding the adverse effects within the full texts, lack of follow-up, and risk of bias. In conclusion, there were multiple adverse effects that clinicians should consider prior to carrying out LADD, where treatment goals and patient tolerability should be considered. Further evidence is needed to quantitatively determine these risks.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据